Abstract

AbstractLanthanide nanoparticle (LnNP) scintillators exhibit huge potential in achieving radionuclide‐activated luminescence (radioluminescence, RL). However, their structure–activity relationship remains largely unexplored. Herein, progressive optimization of LnNP scintillators is presented to unveil their structure‐dependent RL property and enhance their RL output efficiency. Benefiting from the favorable host matrix and the luminescence‐protective effect of core–shell engineering, NaGdF4 : 15 %Eu@NaLuF4 nanoparticle scintillators with tailored structures emerged as the top candidates. Living imaging experiments based on optimal LnNP scintillators validated the feasibility of laser‐free continuous RL activated by clinical radiopharmaceuticals for tumor multiplex visualization. This research provides unprecedented insights into the rational design of LnNP scintillators, which would enable efficient energy conversion from Cerenkov luminescence, γ‐radiation, and β‐electrons into visible photon signals, thus establishing a robust nanotechnology‐aided approach for tumor‐directed radio‐phototheranostics.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.